Houda Alachkar

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Cancer research communications

bioRxiv : the preprint server for biology

Cellular & molecular biology letters

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Yiyu Xiao, Qianqian Peng, Advaith Maya Sanjeev Kumar, Houda Alachkar
Low methylthioadenosine phosphorylase expression is associated with worse survival in patients with acute myeloid leukaemia. Clinical and translational medicine 14 (9) (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Dottie Yu, Ram Ayyala, Sarah Hany Sadek, Likhitha Chittampalli, Hafsa Farooq, Junghyun Jung, Abdullah Al Nahid, Grigore Boldirev, Mina Jung, Sungmin Park, Austin Nguyen, Alex Zelikovsky, Nicholas Mancuso, Jong Wha J Joo, Reid F Thompson, Houda Alachkar, Serghei Mangul
A rigorous benchmarking of alignment-based HLA typing algorithms for RNA-seq data. bioRxiv : the preprint server for biology (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific antibody-based nanoparticles (BiAbs) for Acute Myeloid Leukemia. Cancer research communications (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Dottie Yu, Ram Ayyala, Sarah Hany Sadek, Likhitha Chittampalli, Hafsa Farooq, Junghyun Jung, Abdullah Al Nahid, Grigore Boldirev, Mina Jung, Sungmin Park, Austin Nguyen, Alex Zelikovsky, Nicholas Mancuso, Jong Wha J Joo, Reid F Thompson, Houda Alachkar, Serghei Mangul
A rigorous benchmarking of alignment-based HLA typing algorithms for RNA-seq data. bioRxiv : the preprint server for biology (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Amani Alqahtani, Mengxi Wang, Mimi Lou, Houda Alachkar
Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia. Clinical and translational science (2023)
Amani Alqahtani, Diala Alhousari, Amir Ali, George Yaghmour, Etan Orgel, Emily Curran, Wendy Stock, Deepa Bhojwani, Houda Alachkar
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert opinion on drug metabolism & toxicology (2023)
Yiting Meng, Mateusz Pospiech, Atham Ali, Ritu Chandwani, Mary Vergel, Sandra Onyemaechi, George Yaghmour, Rong Lu, Houda Alachkar
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment. Cellular & molecular biology letters 28 (1) (2023)